Slingerland, Sofie
de Meyer, Eline K. R.
van der Horn, Harm J.
Carli, Giulia
Slomp, Anne C.
d’Angremont, Emile
Boertien, Jeffrey M.
Goethals, Ingeborg
Meles, Sanne K.
van der Zee, Sygrid
van Laar, Teus
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson’s Research (MJFF-010551, MJFF-010551)
Article History
Received: 13 July 2025
Accepted: 16 September 2025
First Online: 12 November 2025
Competing interests
: T.v.L. has received grant support from the MJFF, the UMCG, Menzis, Weston Brain Institute and the Dutch Brain Foundation. Consultancy fees were received from AbbVie, Britannia Pharm., Centrapharm and Neuroderm. Speaker fees were received from AbbVie, Britannia Pharm. and Eurocept. J.M.B. has received grant support from the UMCG/RUG, writer fees from Britannia Pharm, speaker fees from Centrapharm, and owns exchange traded funds that might include stocks in medically related fields. The remaining authors declare no competing interests.